X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Divis Laboratories Fact Sheet, Divis Laboratories Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Divis Laboratories Fact Sheet   (DIVI)

Here is the latest financial fact sheet of Divis Laboratories. For more details, see the Divis Laboratories quarterly results and Divis Laboratories share price and chart. For a sector overview, read our pharmaceuticals sector report.

DIVIS LABORATORIES Price History

Price Rs 1,565.1
Mkt Cap Rs m 415,471
Vol '000 15.2
P/E X 31.8
P/CF X 40.8
EPS (TTM) Rs 49.2
% ch % 1.0
No. of shares m 265.47
% ch week % -3.3
% ch 1-mth % 4.2
% ch 12-mth % 53.7
52 week H/L Rs 1,697.7/981.1
(As on Feb 22, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DIVIS LABORATORIES Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
DIVIS LABORATORIES EQUITY SHARE DATA
High Rs1,4591,8812,4841,2221,142 
Low Rs9051,217918784533 
Sales per share (Unadj.) Rs190.8234.7142.3153.1146.6 
Earnings per share (Unadj.) Rs58.364.242.439.933.0 
Diluted earnings per shareRs29.132.142.439.933.0 
Cash flow per share (Unadj.) Rs65.274.446.944.638.4 
Dividends per share (Unadj.) Rs20.0020.0010.0010.0010.00 
Adj. dividends per shareRs10.0010.0010.0010.0010.00 
Dividend yield (eoy) %1.71.30.61.01.2 
Book value per share (Unadj.) Rs223.3288.0161.7201.8222.8 
Adj. book value per shareRs111.6144.0161.7201.8222.8 
Shares outstanding (eoy) m132.73132.73265.47265.47265.47 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x6.26.612.06.65.7 
Avg P/E ratio x20.324.140.125.125.3 
P/CF ratio (eoy) x18.120.836.322.521.8 
Price / Book Value ratio x5.35.410.55.03.8 
Dividend payout %34.331.223.625.030.3 
Avg Mkt Cap Rs m156,887205,599451,525266,266222,318 
No. of employees `000NA8.79.59.710.8 
Total wages/salary Rs m2,3252,9043,6124,9994,561 
Avg. sales/employee Rs ThNM3,571.83,983.14,175.03,616.0 
Avg. wages/employee Rs ThNM333.0381.0513.5423.8 
Avg. net profit/employee Rs ThNM976.41,187.41,089.3814.9 
DIVIS LABORATORIES INCOME DATA
Net Sales Rs m25,32131,14937,76440,64338,915 
Other income Rs m7064479747491,134 
Total revenues Rs m26,02731,59638,73841,39240,049 
Gross profit Rs m10,14511,65214,17414,46012,617 
Depreciation Rs m9211,3601,1821,2331,425 
Interest Rs m2119382313 
Profit before tax Rs m9,90910,72113,92813,95312,313 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m2,1762,2062,6713,3493,543 
Profit after tax Rs m7,7338,51511,25810,6048,770 
Gross profit margin %40.137.437.535.632.4 
Effective tax rate %22.020.619.224.028.8 
Net profit margin %30.527.329.826.122.5 
DIVIS LABORATORIES BALANCE SHEET DATA
Current assets Rs m22,56427,72430,27040,10545,351 
Current liabilities Rs m6,2744,5605,1956,5956,507 
Net working cap to sales %64.374.466.482.599.8 
Current ratio x3.66.15.86.17.0 
Inventory Days Days134136117119127 
Debtors Days Days10487858195 
Net fixed assets Rs m13,66315,23116,99819,99521,160 
Share capital Rs m266266531531531 
"Free" reserves Rs m29,36337,95842,40253,04358,625 
Net worth Rs m29,63438,22342,93353,57459,156 
Long term debt Rs m1611500 
Total assets Rs m37,10543,82949,02161,58567,832 
Interest coverage x482.0577.4369.5618.4926.8 
Debt to equity ratio x00000 
Sales to assets ratio x0.70.70.80.70.6 
Return on assets %20.919.523.017.312.9 
Return on equity %26.122.326.219.814.8 
Return on capital %33.528.132.526.120.8 
Exports to sales %89.284.385.300 
Imports to sales %20.023.922.925.221.8 
Exports (fob) Rs m22,57526,24432,19800 
Imports (cif) Rs m5,0697,4428,65410,2608,485 
Fx inflow Rs m22,61726,31732,27035,38432,359 
Fx outflow Rs m5,1837,5888,77510,3999,042 
Net fx Rs m17,43418,72923,49624,98523,317 
DIVIS LABORATORIES CASH FLOW
From Operations Rs m 5,568 8,263 10,379 11,504 7,759 
From Investments Rs m -3,052 -5,208 -4,064 -11,396 -4,783 
From Financial Activity Rs m -2,485 -3,030 -6,311 24 -3,142 
Net Cashflow Rs m 31 25 3 132 -166 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 52.0%
Foreign collaborators 0.0%
Indian inst/Mut Fund 11.8%
FIIs 19.0%
ADR/GDR 0.0%
Free float 17.2%
Shareholders 31,796
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 7-1-77/E/1/303, Divi Towers, Dharam Karan Road, Ameerpet, Hyderabad-16
E-MAIL cs@divislaboratories.com WEB www.divislaboratories.com
TELEPHONE (040) 2378 6300 FAX (040) 2378 6460
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR P. V. R. K. Nageswara Rao & Co.
CHM: Murali K. Divi (MD) COMP SEC: P. V. Lakshmi Rajani YEAR OF INC: 1990 BSE CODE: 532488 FV (Rs): 2 DIV YIELD (%): 0.6

Read: DIVIS LABORATORIES 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   MERCK LTD  INDRAPRASTHA MEDICAL  DISHMAN PHARMA  PFIZER  IPCA LABS  

Compare DIVIS LABORATORIES With:   MERCK LTD  INDRAPRASTHA MEDICAL  DISHMAN PHARMA  PFIZER  IPCA LABS  

Compare DIVIS LABORATORIES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Recapitalisation Package for PSBs: The Pros & Cons(Podcast)

Corporate governance issues with certain companies, uncertainty surrounding national elections and global issues like trade wars, Brexit, have taken a toll on the Indian markets.

Views on news

DIVIS LABORATORIES Announces Quarterly Results (3QFY19); Net Profit Up 68.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 68.9% YoY). Sales on the other hand came in at Rs 13 bn (up 29.4% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (2QFY19); Net Profit Up 92.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 92.3% YoY). Sales on the other hand came in at Rs 13 bn (up 44.3% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The 4-Point Plan to Accelerate India to a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Feb 12, 2019

Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 8-QTR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS